# The Vascular Effects of Vildagliptin in Insulin Resistant Individuals

> **NCT01122641** · PHASE3 · COMPLETED · sponsor: **Royal Devon and Exeter NHS Foundation Trust** · enrollment: 15 (actual)

## Conditions studied

- Insulin Resistance
- Microvascular Disease

## Interventions

- **DRUG:** Vildagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01122641
- **Lead sponsor:** Royal Devon and Exeter NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-08-01
- **Final completion:** 2014-08-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01122641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01122641, "The Vascular Effects of Vildagliptin in Insulin Resistant Individuals". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01122641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*